1,2,4-Oxadiazolyl- or 1,2,4-thiadiazolyl-biphenyl derivatives as angiotensin II antagonists
申请人:TAKEDA CHEMICAL INDUSTRIES, LTD.
公开号:EP0588299A2
公开(公告)日:1994-03-23
57 The present invention relates to a compounds represented by the following formula or salts thereof.
The above compounds have strong angiotensin II antagonistic action, antihypertensive action and action on central nervous system, which are useful for the treatment of circulatory diseases such as hypertension, heart diseases, cerebral apoplexy, nephritis, atherosclerosis or Alzheimer's disease and senile dementia, and for agents of improving cerebral function.
57 本发明涉及下式所代表的化合物或其盐类。
上述化合物具有很强的血管紧张素 II 拮抗作用、降压作用和对中枢神经系统的作用,可用于治疗循环系统疾病,如高血压、心脏病、脑中风、肾炎、动脉粥样硬化或阿尔茨海默病和老年痴呆症,也可用于改善脑功能的制剂。
Heterocyclic compounds and their use as angiotensin II antagonists
申请人:TAKEDA CHEMICAL INDUSTRIES, LTD.
公开号:EP0829479A1
公开(公告)日:1998-03-18
The present invention relates to a compounds represented by the following formula or salts thereof.
The above compounds have strong angiotensin II antagonistic action, antihypertensive action and action on central nervous system, which are useful for the treatment of circulatory diseases such as hypertension, heart diseases, cerebral apoplexy, nephritis, atherosclerosis or Alzheimer's disease and senile dementia, and for agents of improving cerebral function.
本发明涉及下式所代表的化合物或其盐类。
上述化合物具有很强的血管紧张素 II 拮抗作用、降压作用和对中枢神经系统的作用,可用于治疗循环系统疾病,如高血压、心脏病、脑中风、肾炎、动脉粥样硬化或阿尔茨海默病和老年痴呆症,也可用于改善脑功能的制剂。
US5500427A
申请人:——
公开号:US5500427A
公开(公告)日:1996-03-19
[EN] ANGIOTENSIN II RECEPTOR ANTAGONISTS
申请人:ABBOTT LABORATORIES
公开号:WO1993017682A1
公开(公告)日:1993-09-16
(EN) Compounds are disclosed having formula (I). The compounds of the invention are angiotensin II receptor antagonists.(FR) Composés de la formule (I) qui sont des antagonistes des récepteurs de l'angiotensine II.
Cyclic compounds and their use
申请人:Takeda Chemical Industries, Ltd.
公开号:US05500427A1
公开(公告)日:1996-03-19
The present invention relates to a compounds represented by the following formula or salts thereof. ##STR1## The above compounds have strong angiotensin II antagonistic action, antihypertensive action and action on central nervous system, which are useful for the treatment of circulatory diseases such as hypertension, heart diseases, cerebral apoplexy, nephritis, atherosclerosis or Alzheimer's disease and senile dementia, and for agents of improving cerebral function.